Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 93

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 93
---
 or approximately $ per share. This represents an immediate increase in net tangible book value to existing shareholders of $ per share and an immediate dilution in net tangible book value of $per share of our common stock to the investors purchasing securities in this offering. The following table illustrates this per share dilution to the new investors purchasing shares of common stock in this offering:

| Combined public offering price per share of common stock and accompanying Warrants                  
 Historical net tangible book value (deficit) per share as of September 30, 2024                     | ​ | ​ | ​      
 (0.24) | ​ | ​ | ​ 
 ​ |
|:----------------------------------------------------------------------------------------------------|:--|:--|:-------|:--|:--|:--|
| Increase in net tangible book value per share attributable to investors purchasing in this offering | ​ | $ | ​      | ​ | ​ | ​ |
| As adjusted net tangible book value per share as of September 30, 2024 after this offering          | ​ | ​ | ​      | ​ | $ | ​ |
| Dilution per share to investors purchasing in this offering                                         | ​ | ​ | ​      | ​ | $ | ​ |

The foregoing discussion and tables above are based on 36,827,671 shares of common stock outstanding as of September 30, 2024, and excludes:

| ● | 76,112 shares of our common stock issuable upon the exercise of outstanding stock options as of September 30, 2024, with a weighted-average exercise price of $85.95 per share; |

| ● | 11,379 shares of common stock issuable upon the vesting and settlement of outstanding restricted stock units as of September 30, 2024; |

| ● | 60,957,004 shares of our common stock issuable upon the exercise of outstanding warrants as of September 30, 2024, with a weighted-average exercise price of $0.29 per share; |

| ● | 56,359 shares of our common stock issuable upon conversion of the Class A Common Stock, at the holders’ election; |

| ● | 16,666 shares of our common stock issuable upon conversion of the Class A Preferred Stock, at the holders’ election; |

| ● | 398,317 shares of our common stock reserved for future issuance under the 2016 Plan, plus any future increases in the number of shares of common stock reserved for issuance thereunder; and |

| ● |